Crowdonomics
All companies
Beverly Hills Rejuvenation Center logo

Beverly Hills Rejuvenation Center

Operating

Healthcare · Los Angeles, CA

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$0
Across 1 round since 2024
Latest share price
$1.00
Reg CF Offering (2024) offering price

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source
$760K
$90K
2022
$539K
$228K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$760,492
$539,257
Cost of goods sold
$530,549
$259,638
Gross margin
30%
52%
Net income
$90,203
$227,965
Taxes paid
$0
$0
Balance sheet
Cash
$373,958
$48,300
Accounts receivable
$353,416
$341,366
Total assets
$1,716,761
$1,237,964
Short-term debt
$257,095
$423,331
Long-term debt
$874,289
$758,423
Total liabilities
$1,131,384
$1,181,754
Other
Headcount
—
3

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Cap table

Principal holders% as the filing states it, Nov 21, 2024

  • Dan Holtz49.0%of company
  • Devin Haman49.0%of company

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · Common Stock · Nov 2024Closedvia Title3Funds LLC
Raised $0 / $1.2M

Team

5 people
Dan HoltzFounder
Founder, CEO
Devin Haman
CEO
Christiana White
Sr. Vice President
Alexandra McGuan
Sr. Director Sales and Business Development Corporate and Franchise
David Tiktin
Comptroller

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form CNov 21, 20240002040468-24-000002
    EDGAR
Source: SEC EDGARCIK 0002040468CAShare price $1.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.